Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy

There is no fulltext present in this item.

Title:	Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy
Author(s):	Bloemendal, M. ; Rietveld, M.J.A.; Willigen, W.W. van; Gerritsen, W.R. ; Figdor, C.G. ; Bonenkamp, J.J. ; Westdorp, H.; Boudewijns, S; Koornstra, R.H. ; Adang, E.M.M. ; Schreibelt, G. ; Ottevanger, P.B. ; Vries, I.J.M. de ; Bol, K.F.
Publication year:	2019
Source:	Clinical & Translational Oncology, vol. 21, iss. 6, (2019), pp. 774-780
ISSN:	1699-048X
DOI:	https://doi.org/10.1007/s12094-018-1987-0
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/203875
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 14: Tumours of the digestive tract RIHS: Radboud Institute for Health Sciences Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences Radboudumc 2: Cancer development and immune defence RIHS: Radboud Institute for Health Sciences Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences
Organization:	Medical Oncology Tumorimmunology Surgery Health Evidence IQ Healthcare
Journal title:	Clinical & Translational Oncology
Volume:	vol. 21
Issue:	iss. 6
Page start:	p. 774
Page end:	p. 780